Supreme Court Rejects Sunny Balwani Appeal in Theranos Case

Former Theranos executive Ramesh "Sunny" Balwani will remain in federal prison after the U.S. Supreme Court declined to hear his appeal in October 2026, preserving his convictions for defrauding investors and patients. Balwani is serving a 12-year-and-11-month sentence at FCI Terminal Island in San Pedro, California, following the collapse of the blood-testing company.

According to A&E, the court's decision leaves intact all 12 convictions returned against Balwani in 2022. The charges stemmed from allegations that he and Theranos founder Elizabeth Holmes misrepresented the capabilities of the company's testing technology, its financial outlook and its commercial relationships.

Prosecutors presented evidence that Theranos marketed machines as capable of conducting numerous blood tests from a small finger-prick sample, although the technology could reliably perform only a limited range of tests. Trial evidence also indicated that Balwani helped promote the company's testing services despite knowing that some results could be inaccurate.

Balwani was convicted of conspiracy to defraud investors, six counts of investor-related wire fraud, conspiracy to defraud patients and four counts of wire fraud involving patients. He pleaded not guilty to the charges.

In his appeal, Balwani argued that jurors had not received potentially important context about a 2013 investor call. According to A&E, Holmes told investors during the call that Theranos technology might be deployed in U.S. military equipment but expressed uncertainty about whether that would occur.

The company's financial projections were central to the fraud case. Theranos projected revenue exceeding $100 million in 2014 and approximately $1 billion in 2015, while prosecutors presented evidence that Balwani knew its actual commercial prospects were substantially weaker.

Holmes, who founded Theranos in 2003, received an 11-year-and-three-month federal prison sentence in 2022. Her jury convicted her of investor-related fraud but acquitted her of patient-related fraud charges and failed to reach unanimous verdicts on three additional investor-fraud counts.

Courts ordered Holmes and Balwani to pay more than $452 million in restitution, with the obligation assigned to either defendant or jointly. The order covered losses associated with the fraud case against the former Theranos executives.

According to A&E, Balwani joined Theranos in September 2009 after investing millions of dollars in the company. As president and chief operating officer, he oversaw software development, personnel and daily operations while maintaining a relationship with Holmes that lasted until 2016, according to court documents cited by the outlet.

The pair first met in 2002 during a Stanford University Mandarin language immersion program in Beijing. Holmes was an 18-year-old high school senior, while Balwani was a 37-year-old businessman. They began dating in 2004, the same year Holmes left Stanford to focus on building Theranos.